Evidence map›Paper›PMID 41669668›Full record

ArticleNAR genomics and bioinformatics2026

A comprehensive annotation of conserved protein domains in human endogenous retroviruses.

Tomàs Montserrat-Ayuso, Aurora Pujol, Anna Esteve-Codina

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tomàs Montserrat-AyusoCentre Nacional d'Anàlisi Genòmica (CNAG), Baldiri Reixac 4, 08028 Barcelona, Spain.ORCID https://orcid.org/0009-0009-0212-9768
Aurora PujolNeurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.ORCID https://orcid.org/0000-0002-9606-0600
Anna Esteve-CodinaCentre Nacional d'Anàlisi Genòmica (CNAG), Baldiri Reixac 4, 08028 Barcelona, Spain.ORCID https://orcid.org/0000-0003-0361-2873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human endogenous retroviruses (HERVs) occupy nearly 8% of the human genome, yet their protein-coding potential remains largely unexplored. Originating from ancestral retroviruses that infected germline cells, HERVs typically follow the canonical proviral structure LTR-gag-pol-env-LTR, where gag, pol, and env encode structural, enzymatic, and envelope proteins. We present a comprehensive resource annotating conserved retroviral domains across 120 000 + ORFs derived from internal HERV regions. Using a reproducible pipeline based on HMMER and InterProScan, we identified over 17 000 domain hits-primarily from pol genes such as reverse transcriptase, RNase H, and protease-and quantified their structural conservation. Hundreds of domains exceed 95% alignment coverage, revealing a surprising abundance of full-length retrovirus-like domains in both young and ancient families. The HERVK (HML-2) subfamily retains the most complete polyprotein architecture, including 13 loci with nearly intact Gag, Pol, and Env, but full-length Pol domains are also found in HERVH, HERVW, and HERVE. Our annotations recover conserved catalytic motifs in Pol and transmembrane features in Env, enabling fine-grained functional interpretation. All results-including BED, FASTA, domain sequences, InterProScan outputs, and transmembrane predictions-are provided as an open resource at Zenodo to support downstream analyses of HERV protein expression, immune modulation, and co-option in health and disease.

Indexed as

Endogenous RetrovirusesMolecular Sequence AnnotationConserved SequenceGenome, HumanHumansOpen Reading FramesProtein Domains

Identifiers

PMID41669668
PMCPMC12884080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.